Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bexion Pharmaceuticals Announces the Opening of Phase I Part 3 First-in-Human Trial Using BXQ-350 for the Treatment of Cancer

firstwordpharmaFebruary 24, 2019

Tag: Bexion Pharmaceuticals , BXQ-350 , First-in-Human Trial Using

PharmaSources Customer Service